BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22105784)

  • 1. Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease.
    Namdar M; Steffel J; Jetzer S; Schmied C; Hürlimann D; Camici GG; Bayrak F; Ricciardi D; Rao JY; de Asmundis C; Chierchia GB; Sarkozy A; Lüscher TF; Jenni R; Duru F; Brugada P
    Am J Cardiol; 2012 Feb; 109(4):587-93. PubMed ID: 22105784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of electrocardiography and echocardiography in distinguishing Fabry disease from sarcomeric hypertrophic cardiomyopathy.
    Junqua N; Legallois D; Segard S; Lairez O; Réant P; Goizet C; Maillard H; Charron P; Milliez P; Labombarda F
    Arch Cardiovasc Dis; 2020; 113(8-9):542-550. PubMed ID: 32771348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Electrocardiography to Distinguish Fabry Disease from Sarcomeric Hypertrophic Cardiomyopathy.
    Antezana-Chavez E; Cianciulli TF; Hadid CL; Toro DD; Celano L; Saccheri MC; Baez KG; Lopez CA; Labadet CD; Gagliardi JA
    Am J Cardiol; 2022 Sep; 178():131-136. PubMed ID: 35810008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Electrocardiogram in the Differentiation of Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy.
    Huang J; Zhao S; Chen Z; Zhang S; Lu M
    Int Heart J; 2015; 56(5):522-6. PubMed ID: 26346516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
    Lazzeri C; Barletta G; Badia T; Capalbio A; Del Bene R; Franchi F; Gensini GF; Michelucci A
    Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study.
    Kubo T; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yamanaka S; Iiyama T; Kumagai N; Furuno T; Sugiura T; Kitaoka H
    BMC Cardiovasc Disord; 2015 Jun; 15():53. PubMed ID: 26077897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel electrocardiographic screening criterion for hypertrophic cardiomyopathy in children.
    Brothers MB; Oster ME; Ehrlich A; Strieper MJ; Mahle WT
    Am J Cardiol; 2014 Apr; 113(7):1246-9. PubMed ID: 24513471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?
    Gustavsson S; Granåsen G; Grönlund C; Wiklund U; Mörner S; Henein M; Suhr OB; Lindqvist P
    Amyloid; 2015; 22(3):163-70. PubMed ID: 26104852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between global longitudinal strain and QRS voltage on electrocardiogram in patients with left ventricular hypertrophy.
    Beladan CC; Popescu BA; Calin A; Rosca M; Matei F; Gurzun MM; Popara AV; Curea F; Ginghina C
    Echocardiography; 2014 Mar; 31(3):325-34. PubMed ID: 24015855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Electrocardiographic Voltage to Determine Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
    Konno T; Nagata Y; Teramoto R; Fujino N; Nomura A; Tada H; Sakata K; Furusho H; Takamura M; Nakamura H; Kawashiri MA; Yamagishi M; Hayashi K
    Am J Cardiol; 2016 Feb; 117(3):443-9. PubMed ID: 26705881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis.
    Cariou E; Bennani Smires Y; Victor G; Robin G; Ribes D; Pascal P; Petermann A; Fournier P; Faguer S; Roncalli J; Rousseau H; Chauveau D; Carrié D; Berry I; Galinier M; Lairez O;
    Amyloid; 2017 Jun; 24(2):101-109. PubMed ID: 28553897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data).
    Greve AM; Gerdts E; Boman K; Gohlke-Baerwolf C; Rossebø AB; Hammer-Hansen S; Køber L; Willenheimer R; Wachtell K
    Am J Cardiol; 2011 Aug; 108(4):541-7. PubMed ID: 21624542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
    Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO
    Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy.
    Caselli S; Maron MS; Urbano-Moral JA; Pandian NG; Maron BJ; Pelliccia A
    Am J Cardiol; 2014 Nov; 114(9):1383-9. PubMed ID: 25217454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease.
    Takeda M; Amano Y; Tachi M; Tani H; Mizuno K; Kumita S
    Jpn J Radiol; 2013 Oct; 31(10):693-700. PubMed ID: 23996116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic signs of hypertrophy in fabry disease-associated hypertrophic cardiomyopathy.
    Kampmann C; Wiethoff CM; Martin C; Wenzel A; Kampmann R; Whybra C; Miebach E; Beck M
    Acta Paediatr Suppl; 2002; 91(439):21-7. PubMed ID: 12572838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of extended-length electrocardiogram in differentiating between athlete's heart and hypertrophic cardiomyopathy.
    Caselli L; Galanti G; Padeletti L; Nieri M; Cecchi F; Cipollini F; Baldi M; Perrotta L; Vignini S; Michelucci A
    J Electrocardiol; 2009; 42(6):636-41. PubMed ID: 19577245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.